Jiangsu Vcare Pharmatech Co., Ltd.
PrivateLast Round
Series C
Extension
Jun 2, 2026
Total Funding Raised
$224.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Jiangsu Vcare Pharmatech Co., Ltd. operates in Healthcare & Life Sciences and is based in Nanjing. Its latest recorded funding round was a Series C Extension round in June 2026.
Jiangsu Vcare Pharmatech Co., Ltd. is a biopharmaceutical company that focuses on innovative drug research and development and provides comprehensive pharmaceutical industry chain services including CRO and CDMO.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jiangsu Vcare Pharmatech Co., Ltd. Comparables
Compare Jiangsu Vcare Pharmatech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioDuro-Sundia | 74% | |
| Bayer AG | 73% | |
| Eli Lilly and Company | 73% |
For institutional investors. Book with your work email.
Jiangsu Vcare Pharmatech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jun 2, 2026 | ||||
| Series C Extension | Jan 22, 2025 | ||||
| Series C | Jan 2, 2024 | ||||
| Series B | Dec 26, 2022 | ||||
| Series A | May 6, 2022 | ||||
Series A | Jul 29, 2021 |
For institutional investors. Book with your work email.
Jiangsu Vcare Pharmatech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hongcheng Capital | Series B |
| DYEE Capital | Series C |
| SDIC Capital Co., Ltd. | Series C Extension, Series B, Series A |
| 南京市创新投资集团有限责任公司 | Series C, Series A |
| China Life Private Equity Investment | Series C |
| Yangtze River Industry Group | Series A, Series B |
| China Life Private Equity Investment Co., Ltd. | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 133% MoM.
- Jun 2, 2026
$29.4M round completed.
For institutional investors. Book with your work email.
Jiangsu Vcare Pharmatech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Jiangsu Vcare Pharmatech Co., Ltd.'s valuation, stock price, and market status.
Is Jiangsu Vcare Pharmatech Co., Ltd. a public or private company?
Jiangsu Vcare Pharmatech Co., Ltd. is a private company.
What is the current stock price of Jiangsu Vcare Pharmatech Co., Ltd.?
Jiangsu Vcare Pharmatech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Jiangsu Vcare Pharmatech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Jiangsu Vcare Pharmatech Co., Ltd. worth (valuation)?
Valuation information for Jiangsu Vcare Pharmatech Co., Ltd. is not publicly available.
Can I buy Jiangsu Vcare Pharmatech Co., Ltd. stock?
Jiangsu Vcare Pharmatech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Jiangsu Vcare Pharmatech Co., Ltd.'s last funding round?
Jiangsu Vcare Pharmatech Co., Ltd.'s most recent funding round was Series C Extension on June 2, 2026.
Who are the main investors in Jiangsu Vcare Pharmatech Co., Ltd.?
Key investors in Jiangsu Vcare Pharmatech Co., Ltd. include DYEE Capital, SDIC Capital Co., Ltd., China Life Private Equity Investment.
Will Jiangsu Vcare Pharmatech Co., Ltd. IPO soon?
No public IPO plans have been announced for Jiangsu Vcare Pharmatech Co., Ltd..
How can I track Jiangsu Vcare Pharmatech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Jiangsu Vcare Pharmatech Co., Ltd.'s shares on secondary markets.